Literature DB >> 12381947

Idiopathic IgA nephropathy with diffuse crescent formation.

Zheng Tang1, Yan Wu, Qing-wen Wang, Yu-sheng Yu, Wei-xing Hu, Xiao-dan Yao, Hui-ping Chen, Zhi-hong Liu, Lei-shi Li.   

Abstract

OBJECTIVE: To investigate the clinicopathological features and outcome of idiopathic IgA nephropathy with diffuse crescent formation in Chinese patients.
METHODS: Twenty-five patients with diffuse crescentic IgA nephropathy (DCIgAN), 15 males and 10 females with median age of 28.5, and median disease duration of 5.1 months, were studied. Their clinical, laboratory and pathological features and outcome were investigated. Twenty-one were administered pulse immunosuppressive therapy, and 15 were followed up for more than 6 months.
RESULTS: 1.14% had total IgA nephropathy, and 16.4% total diffuse crescentic glomerulonephritis. Clinically, most of patients (88%) showed rapidly progressive glomerulonephritis associated with a high level of serum creatinine (418 +/- 264 micromol/l). Gross hematuria was noted in 72%, hypertension in 64%, and nephrotic syndrome in 48%. Pathologically, except for diffuse crescent formation (a median 65% and range 50-95%), we observed segmental necrosis of glomerular capillaries in 60%, glomerular infiltrating cells in 48%, endothelial cells proliferation in 32%, and rupture of Bowmans' capsule in 24%. Severe tubular interstitial damage was also found, tubular atrophy in 64%, interstitial fibrosis in 60%, diffuse interstitial infiltrating cells in 74%, and interstitial vasculitis in 40%. Immunopathologically, four phenotypes were observed; however, IgA associated with IgM deposition was higher than that in patients with general IgA nephropathy (IgAN). In addition, the infiltrating CD4+, CD8+, CD68+ and PCNA+ cells in renal tissue were significantly high compared with that in controls. In a follow-up study, 66.7% of patients had life-sustaining renal function, 4 of them had normal range of serum creatinine (<124 micromol/l), and only 5 were dialysis-dependent.
CONCLUSIONS: The patients with crescentic IgA nephropathy mostly show rapidly progressive nephritis associated with more severe pathological changes including glomerular, tubular interstitial and vascular lesions than in patients with general IgAN. The infiltrates in glomeruli may contribute to the crescentic formation, and the intensive immune suppressing treatment is useful to improve renal damage in patients with DCIgAN. Copyright 2002 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12381947     DOI: 10.1159/000065281

Source DB:  PubMed          Journal:  Am J Nephrol        ISSN: 0250-8095            Impact factor:   3.754


  16 in total

1.  Prediction of outcomes in crescentic IgA nephropathy in a multicenter cohort study.

Authors:  Jicheng Lv; Yihe Yang; Hong Zhang; Wenfang Chen; Xiaoxia Pan; Zhiling Guo; Caili Wang; Shen Li; Jianrong Zhang; Jianchun Zhang; Lijun Liu; Sufang Shi; Suxia Wang; Min Chen; Zhao Cui; Nan Chen; Xueqing Yu; Minghui Zhao; Haiyan Wang
Journal:  J Am Soc Nephrol       Date:  2013-09-12       Impact factor: 10.121

2.  Reversal of active glomerular lesions after immunosuppressive therapy in patients with IgA nephropathy: a repeat-biopsy based observation.

Authors:  Xia-Hong Shen; Shao-Shan Liang; Hui-Mei Chen; Wei-Bo Le; Song Jiang; Cai-Hong Zeng; Min-Lin Zhou; Hai-Tao Zhang; Zhi-Hong Liu
Journal:  J Nephrol       Date:  2015-01-14       Impact factor: 3.902

Review 3.  Treatment of IgA nephropathy and Henoch-Schönlein nephritis.

Authors:  Jürgen Floege; John Feehally
Journal:  Nat Rev Nephrol       Date:  2013-04-02       Impact factor: 28.314

4.  Crescentic IgA nephropathy in children.

Authors:  Yuko Shima; Koichi Nakanishi; Taketsugu Hama; Hironobu Mukaiyama; Masashi Sato; Yu Tanaka; Ryojiro Tanaka; Hiroshi Kaito; Kandai Nozu; Mayumi Sako; Kazumoto Iijima; Norishige Yoshikawa
Journal:  Pediatr Nephrol       Date:  2020-01-28       Impact factor: 3.714

5.  The effect of immunosuppressive therapy in patients with fibrinoid necrosis lesions in a large cohort of patients with IgA nephropathy.

Authors:  Yingman Guo; Sufang Shi; Xujie Zhou; Lijun Liu; Jicheng Lv; Li Zhu; Suxia Wang; Hong Zhang
Journal:  J Nephrol       Date:  2021-10-21       Impact factor: 3.902

Review 6.  Corticosteroids in IgA Nephropathy: Lessons from Recent Studies.

Authors:  Rosanna Coppo
Journal:  J Am Soc Nephrol       Date:  2016-09-26       Impact factor: 10.121

7.  Correlation of immunostaining findings with demographic data and variables of Oxford classification in IgA nephropathy.

Authors:  Hamid Nasri; Shahram Sajjadieh; Saeed Mardani; Ali Momeni; Alireza Merikhi; Yahya Madihi; Alaleh Ghiessari; Afsoon Emami Naieni
Journal:  J Nephropathol       Date:  2013-07-01

8.  Location of glomerular immune deposits, not codeposition of immunoglobulin G, influences definitive renal outcomes in immunoglobulin A nephropathy.

Authors:  Anthony S Alvarado; Nicole K Andeen; Sergey Brodsky; Alice Hinton; Tibor Nadasdy; Charles E Alpers; Christopher Blosser; Behzad Najafian; Brad H Rovin
Journal:  Nephrol Dial Transplant       Date:  2018-07-01       Impact factor: 5.992

9.  Non-infectious aortitis in an immunosuppressed renal transplant recipient with IgA nephropathy.

Authors:  Charlotte M Snead; Stephen C Crockett; Phillippa K Bailey
Journal:  BMJ Case Rep       Date:  2017-10-19

10.  Etiological Spectrum and Clinical Features in 215 Patients of Crescentic Glomerulonephritis: Is it Different in India?

Authors:  Anubha Gupta; Vinita Agrawal; Anupma Kaul; Ritu Verma; Manoj Jain; Narayan Prasad; Rakesh Pandey
Journal:  Indian J Nephrol       Date:  2021-03-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.